Gene: TMEM255B
Official Full Name: transmembrane protein 255Bprovided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13178 | TMEM255B Knockout cell line (HCT 116) | Human | TMEM255B | 1:2~1:4 | Negative | Online Inquiry |
KO13179 | TMEM255B Knockout cell line (HEK293) | Human | TMEM255B | 1:3~1:6 | Negative | Online Inquiry |
TMEM255B Gene Knockout Cell Lines are genetically engineered cell lines characterized by the complete disruption of the TMEM255B gene, a crucial player in various cellular functions including immune response and cell signaling pathways. Utilizing the powerful CRISPR-Cas9 gene-editing technology, these cell lines enable researchers to dissect the specific roles of TMEM255B in cellular processes, thereby providing insights into its contribution to diseases such as cancer, autoimmune disorders, and other pathologies.
The key mechanism of action of TMEM255B Gene Knockout Cell Lines revolves around the loss of function of the TMEM255B gene. This knockout model allows for the examination of compensatory pathways and alternative signaling mechanisms that can emerge in the absence of functional TMEM255B. Such investigations are integral to understanding disease mechanisms and developing targeted therapies.
In research and clinical settings, these cell lines hold substantial scientific importance. They offer a platform for high-throughput screening of therapeutic compounds, facilitating the identification of potential drugs that can restore normal function in TMEM255B-deficient cells. Moreover, they provide a valuable tool for studying gene interactions and the resultant phenotypic changes, thus advancing our understanding of cellular biology.
What sets TMEM255B Gene Knockout Cell Lines apart from alternatives is the precision with which the gene has been targeted, resulting in a complete null phenotype that enhances the reliability of experimental outcomes. Additionally, these cell lines come with robust characterization data, ensuring that researchers can achieve reproducible results.
The value of this product lies in its ability to empower researchers and clinicians with the tools necessary for cutting-edge investigations into gene function and its implications for human health. By integrating these knockout models into their workflows, scientists can accelerate discoveries that may ultimately lead to novel therapeutic strategies.
Our company specializes in providing high-quality biological products backed by substantial expertise in genetic engineering and cell line development, ensuring that our customers receive not only the best products but also exceptional support to enhance their research endeavors.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.